FOR HEALTHCARE PROFESSIONALS
Now FDA Approved!


  • The first and only FDA-approved filler to correct age-related volume
    loss in the midface.2 With optimal treatment, natural-looking results
    last up to 2 years2,3
VOLUMA(R) box

*Required for
 product purchase.

  • 1. Data on file, Allergan, Inc.; Worldwide Dermal Facial Filler Market Overview, Q4 2013.
  • 2. JUVÉDERM VOLUMA® XC Directions for Use, 2013.
  • 3. Data on file, Allergan, Inc.
2. JUVÉDERM VOLUMA® XC Directions for Use, 2013.
 
Kathy
Kathy
Unretouched photos of paid model taken before treatment and 1 month after treatment.
Tami
Tami
Unretouched photos of paid model taken before treatment and 1 month after treatment.

Before

Before

After

After
Individual results may vary.
Right
Left
Above

A total of 3.5 mL of JUVÉDERM VOLUMA® XC was injected into the zygomatic arch, anteromedial cheek, and submalar region.
In the clinical trial, the total volume injected ranged from 1.2 mL to 13.9 mL, with a median of 6.6 mL, to achieve optimal
correction for all 3 subregions.2
A total of 4.8 mL of JUVÉDERM VOLUMA® XC was injected into the zygomatic arch, anteromedial cheek, and submalar region.
In the clinical trial, the total volume injected ranged from 1.2 mL to 13.9 mL, with a median of 6.6 mL, to achieve optimal
correction for all 3 subregions.2

logos

Logos

Download the JUVÉDERM VOLUMA® XC logos for use in both printed and online materials.

Download Video

Video

Download the JUVÉDERM VOLUMA® XC In-Office Patient Video.

brochure

Patient Brochure

Download the JUVÉDERM VOLUMA® XC Patient Brochure.

Please note: Documents are provided in Adobe® Reader® format (PDF). To view PDF documents, you must have the Adobe® Reader® software installed on your computer.

If you do not have Adobe® Reader®, you can download it from the Adobe® website.